{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:59:08Z","timestamp":1761746348864,"version":"build-2065373602"},"reference-count":24,"publisher":"Wiley","issue":"11c","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>Study Type \u2013 Therapy (case series)<\/jats:p>\n                    <jats:p>Level of Evidence\u20034<\/jats:p>\n                    <jats:p>\n                      <jats:bold>What's known on the subject? and What does the study add?<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Several studies describe a reduction of symptomatic urinary tract infections in patients with neurogenic detrusor overactivity after intradetrusor injections of botulinum neurotoxin A (BoNT\/A). It was, however, unclear if a direct antibacterial effect of BoNT\/A plays a role in this clinical observation.<\/jats:p>\n                    <jats:p>This is the first study to investigate a potential antibacterial effect of two frequently used BoNT\/A formulations (i.e. Botox\u00ae and Dysport\u00ae), providing evidence that BoNT\/A does not exert an antibacterial effect on lower urinary tract pathogens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>To determine a potential direct antimicrobial effect of botulinum neurotoxin type A (BoNT\/A).<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>\n                            A prospective study was carried out using onabotulinumtoxin A (Botox\u00ae) and abobotulinumtoxin A (Dypsort\u00ae) in agar diffusion and broth microdilution assays with various clinical urinary tract isolates (\n                            <jats:italic>Escherichia coli<\/jats:italic>\n                            ,\n                            <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                            ,\n                            <jats:italic>Enterobacter cloacae<\/jats:italic>\n                            ,\n                            <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                            ,\n                            <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                            ,\n                            <jats:italic>Citrobacter freundii<\/jats:italic>\n                            ,\n                            <jats:italic>Klebsiella oxytoca and Bacillus subtilis<\/jats:italic>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Inhibition zones (mm) of bacteria around a disc containing 20\u2003\u00b5L saline with 4\u2003IU of Botox\u00ae were measured in the agar diffusion assay.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Minimal inhibitory concentrations (MICs, IU\/mL) of both toxins for all bacteria were determined in the broth microdilution assay after overnight incubation at 35\u2003\u00b0C.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>There was no inhibition zone in the agar diffusion assays with any bacterial strain.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The microdilution test using Botox\u00ae and Dysport\u00ae showed bacterial growth in all dilutions, i.e. MICs\u2003&gt;\u200320 and &gt;100\u2003IU\/mL for Botox\u00ae and Dysport\u00ae, respectively.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"explicit-label\">\n                        <jats:list-item>\n                          <jats:p>BoNT\/A has no direct antimicrobial effect.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The reduced frequency of symptomatic urinary tract infections (sUTIs) in patients with neurogenic detrusor overactivity (NDO) after BoNT\/A intradetrusor injections seems to be caused by different indirect mechanisms, which are still not completely understood.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11414.x","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T08:21:49Z","timestamp":1344500509000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Is there a direct antimicrobial effect of botulinum neurotoxin type A?"],"prefix":"10.1111","volume":"110","author":[{"given":"Jens","family":"W\u00f6llner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathrin","family":"Schmidig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Gregorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.09.009"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.001"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.12.012"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.02.031"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.08.039"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-009-0466-1"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09435.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08402.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.01.117"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-008-0362-0"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05368_7.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.01.102"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-33079-1_44"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2007.07.009"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21814"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.03.016"},{"key":"e_1_2_7_18_2","first-page":"1","article-title":"Prevention and management of urinary tract infections in paralyzed persons","volume":"6","author":"Vickrey BG","year":"1999","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.07.114"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.02.063"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.21078"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.4049\/jimmunol.145.4.1214","article-title":"Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation","volume":"145","author":"Kowalski ML","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb39781.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2003.10.008"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.07.018"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11414.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11414.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:14:03Z","timestamp":1761736443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11414.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":24,"journal-issue":{"issue":"11c","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11414.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11414.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2012,8,9]]},"assertion":[{"value":"2012-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}